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Summary 
The action of peritoneal exudate cells (PEC) from normal and vaccinia virus 
infected mice on infectious vaccinia virus particles was investigated in vitra. 
PEC from immune mice showed a significantly higher infectivity titre reduction 
(virus clearance, VC) than normal cells. This effect could be clearly attributed to 
the macrophage. Vaccinia virus multiplied in PEC from normal animals while 
there was no virus propagation in cells from immunized mice. The release of 
adsorbed or engulfed virus was reduced significantly in PEC from immunized 
animals. Anti-vaccinia-antibodies seem to activate normal macrophages to 
increased virus clearance. This stimulating effect was demonstrable only in the 
IgG fraction of the antiserum. 
The activity of macrophages from mice injected three times over aperiod of 
14 days with vaccinia virus could be entirely blocked with anti-mouse-IgG, while 
PEC from mice injected one time six days previously were not inhibited. 
Introduction 
Macrophages play a special role in resisting viral infections. This has been 
investigated by various in viva and in vitra experiments, but often with inconsistent 
results. Different forms of interaction between macrophages and virus particles 
have been noted. During the infection with Newcastle disease virus and vesicular 
stomatitis virus macrophages may act on these viruses as on inert particles (5) 
which has been shown by blood clearance assays. However, direct interactions 
between liver macrophages and viruses may be different. Poliovirus type 1 is 
not cleared hom the blood by macrophages (14), the propagation of ectromelia 
virus has been found to be, depending on the virulence of the strain, supported in 
macrophages (13). Genetical factors seem to be responsible for the resistance or 
susceptibility of macrophages to some viral infections, as shown in the MHV-3 
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infection (2, 8). Also the maturity of the phagocytotic cell seems to act af; a 
resistance factor during the infection with herpes virus (10, 11). Macrophages from 
immunized animals have an increased phagocytotic potential (9, 22, 25), but 1itt1e 
is known about the virus specificity of this increased activity (21). In this paper 
we describe the action of peritonea1 exudate cells (PEe) from normal and immune 
mice on infectious vaccinia virus. We compared the different activities of normal 
and immune macrophages on c1earance, inactivation and release of engulfed or 
adsorbed virus particles as weIl as the possible ro1e of antibodies in these reactions. 
Materials and Metllods 
VirU8e8 
Vaccinia virus, strain \'VR 104-106 . 5 TCID 50/ml was propagated and titrated in 
Vero-cells (African green monkey kidney) cultivated in Eagle's MEM containing 
10 per cent inactivated calf serum, 100 lU/mI penicillin and 100 [lg/ml streptomycin. 
Herpes simplex virus, type 1 strain Hof, 105-106 .5 TClDso/ml was propagated and 
titrated in Vero-cells. 
Animal8 
Conventionally maintained C57/BL/6J and CaH/TlF male mice (G. L. Bomholt-
gard Ry Denmark) were used throughout. 
I n/ectivity Titre Determination 
TCID 50/ml was determined according to the method of REED and MUENCH (20). 
Vero-cells were plated in microtiterplates (System Cooke, Greiner Nürtingen M220 
ART). Dilution of virus was performed in log 10 steps. 8 wells were used for each dilution 
step. The plates were incubated at 36° C in humidified 5 per cent CO2-atmosphere. 
Examination and ca1culation of the plates was performed on day 4. 
Preparation 0/ Peritoneal Exudate Cell8 (P EC) 
The mice were injected intraperitoneally with 2 ml thioglycolate (Merck, Darm-
stadt, No. 8190) two days before the harvesting of cells.Micewerekilled byneck disloca· 
tion, the peritoneal cavity was then injected with 5 ml MEM containing 5 IU heparin 
(Trombovetren, Prornonta, Hamburg). The abdomen was gently massaged and the 
cell rich fluid aspirated under sterile conditions. The cell suspensions, mainly macro-
phages, usually contained about 1 X 107 cells per animaI. The cells from 6-8 animals 
were pooled and washed two times with MEM. After viability testing by trypan blne 
exclusion thc cells were counted and concentrated to 1 X 107 cells/mI. 
Sepamtion 0/ Macrophage8 
Macrophages were prepared from PEC by adherence properties. 1.2 X 107 PEC in 
2 ml MEM containing 20 per cent calf serum were added to petri dishes (35/10 mm; 
Greiner, Nürtingen) and incubated at 36° C in humidified 5 per cent C02-atmosphere. 
2 hours later the non-adherent cells were taken off after thorough washing of the cell 
lllonolayer using a syringe and al mm gauge needle. Thc non-adherent cells were pooled 
and counted. 80 per cent of the whole cell count of peritoneal cells were determined as 
adherent cells. After further incubation for 20 hours the monolayers were washed again 
thoroughIy. By light microscopic examination more than 99 per cent of cells were 
determined as macrophages, which were spindle-shaped. 
Virus Clearance Test 
5 X 106 PEC from normal 01' vaccinia virus injected mice were suspended in 0.5 ml 
MEM and transferred to sterile plastic tubes (Greiner, Nürtingen, No. 160S). '1'0 each 
tube 0.5 ml vaccinia virus suspension was added. Controls contained only MEM and 
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virus. The tests were run using at least 3 tubes for each virus-cell suspension. The tubes 
were incubated at 36° C in a humidified 5 per cent CO2 atmosphere for 15 minutes to 
24 hours and then spun down for 5 minutes at 1000 r.p.m. Aliquots of the cell free 
supernatant were removed and the remaining virus infectivity titre in these aliquots 
was titrated in Vero-ceUs. The mean values of TCIDso/ml of the PEC containing 
tubes were compared with the means of the cell free controls. The difference of infectious 
virus in supernatants between PEC containing tubes and control was designated as virus 
clearance (VC) and expressed in percent. The mean TCID 5o/ml of the three control 
tub es in each experiment was taken as 100 per cent. 
Infeetive Oentre Assay 
5 X 106 PEC in 0.5 ml MEM were incubated with 0.5 ml vaccinia virus 105 . 5 TCID 5o/ 
ml for four hours under the same conditions as described above. The ceUs were then 
spun down. To remove non-adsorbed or extraceUular virus, according to the method 
of HIRSCH et al. (10) the ceUs were washed once with MEM, once with a rabbit anti-
vaccinia antibody (50 per cent neutralizing titre: 1:512 diluted 1:10 in MEM), and 
then washed again with MEM. The ceUs were diluted to 100 ceUs/ml and plated on 
Vero-cell monolayers in 35 X 10 mm petri dishes. Counting of plaques was performed 
72 hours later. 
Anti- Vaeeinia Antibody 
Antibodies to vaccinia virus were raised in rabbits by intracutaneous inoculation 
with vaccinia virus and two times challenging after two and foul' weeks by intravenous 
injection of 5 ml vaccinia virus (106 TCID 5o/ml). One week after the last injection the 
animals were bled, serum was prepared, inactivated and stored at -20° C. The neutral-
ization titre was determined according to the method of REED and MUENCH in Iog2 steps. 
A chromatography column, (Pharmacia K 16/40) filled with biogel A 5M, 200-400 
mesh (Biorad Laboratories, München) was used to fractionate the serum. Antiserum 
was fractionated in 36 portions using phosphate buffered saline as dilution fluid. By 
this procedure the serum was diluted ab out 1: 60. The IgM and IgG maximum was 
determined in fraction numbers 20 and 26 by cellulose acetate electrophoresis and 
optical density. 
Results 
Virus Clearance by PEe trom Normal and Imrnunized Mice 
PEC from normal mice and mice injected intraperitoneally on ce or thrce times 
with vaccinia virus (1 ml containing 106 TCID50jml) were investigated for their 
capability to reduce the infectivity titre of a vaccinia virus suspension in vitro. 
PEC were incubated with vaccinia virus (105•5 TCID5o jml) for 24 hOUfS at 37° C. 
Then the cell free supernatant was titrated for virus infectivity. The experiment:;; 
were performed in aserum free medium because serum activates PEC to increased 
unspecific infectivity titre reduction. There is a reduction of infectivity titre of 
25, 38 and 65 per cent after addition of 5, 10 and 20 per cent inactivated calf 
serum respectively. This calf serum had no anti vaccinia antibody activity. The 
titre of the controls was taken as the 100 per cent value and the reduction of virus 
titre, calculated by the method of REED and MUENCH, plotted as percent reduc-
tion. Figure 1 shows the pooled results of six experiments. PEC from normal mice, 
stimulated with thioglycolate, showed a titre reduction oi 16 per cent, PEC from 
one time infected mice reached a reduction of 55 per cent while PEC from three 
times vaccinia injected mice had a 88 per cent infectivity titre reduction. The 
difference of the cell activity from immunized mice compared with that of normal 
mice is significant. 
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Time Dependence 01 V iru8 Glearance 
PEC from normal, and one time and three times vaccinia virus injected mice 
were incubated with vaccinia virus (105•0 TCID5o jml). After 30 minutes, 1, 4, 10 
and 24 hours viral titres in the supernatants were determined in a two-fold assay. 
Controls were run with virus and MEM only (Fig. 2). Virus clearance of macrophages 
began early, showing maximal clearance after one hour. The amount and the time 
course of virus clearance was independent of virus concentration. Even when virus 
suspensions with a low infectivity titre were used the clearance did not reach 
higher percentages. 
700 
w 
Ü 
Z 
« 
er: 
« 60 w 
...J 
Ü 
(fJ 
::J 
er: 
;; 
eR 20 
w 
() 
z 
« 
er: 
« 
w 
...J 
() 
4 10 24 
INCUBATION TIME (hr) 
Fig.l Fig.2 
Fig. 1. VC by PEC fr om normal and immunized mice 
x and SEM of N = 6 experiments, triplicate titration per experiment 
a) PEC cells from normal mice 
b) PEC from mice injected 6 days previously with 1 ml 1 X 106 TCIDso vaccinia virus 
c) PEC from mice injected 3 times with vaccinia virus, first injection 14 days previously 
Differences are significant: a-b p<O.OOl, b-c p<O.OOl 
Fig. 2. Influence of incubation time on VC by PEC from normal and immunized mice 
o - 0 Normal PEC, X - X PEC from mice inj ected with vaccinia virus 6 days pre-
viously, "-,, PEC from mice injected three times with vaccinia virus within 2 weeks 
Gell Specijicity 0/ V iru8 Glearance 
Usually these experiments were performed with PEC. Macrophage monolayers 
were prepared to determine the active cell in virus clearance. The non-adherent 
cells were pooled and concentrated to 5 X 106 cellsjml and the ability of these cells 
to perform virus clearance was investigated. In this assay the infectivity titre 
was not significantly reduced compared to the controls (Table 1). The major part 
of the adherent cells, about 8 X 106, per dish (calculated by subtracting the non-
adherent cells from the whole cell count), had a spindle-like formation after 
24 hours. After 24 hours incubation the cells were washed again. By light micro-
scopic examination of the monolayers the percentage of round lymphoid cells was 
found to be und er 1 per cent. In some experiments macrophages from immunized 
mice showed a reduced tendency to adhere to surfaces, so that the separation of 
adherent cells in these ca ses was accompanied by extensive celliosses. 
2 ml virus suspension (104 . 3 TCID50/ml) was added to each of the dishes. After 
24 hours incubation the supernatant was removed. Macrophages from immunized 
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mice showed 70 per cent virus clearance, while normal macrophages had no 
activity. Macrophages had to be used in this test at a constant time after being 
transferred to the dishes. Cultivation of macrophages in the serum-containing 
medium before the virus clearance test for two and three days resulted in linear 
augmented unspecific virus clearance reaching after three days additionally 
15 per cent to the values we observed, when performing the test at the first day 
of macrophage cultivations. 
Exp. 
No. 
1 
2 
Table 1. Viru8 Glearance by Adherent and Non-Adherent PEG 
OeHs in test 
(5x 106/0_5 ml) 
Non-adherent immune PEO 
Non-adherent normal PEO 
Adherent immune PEO 
Adherent normal PEO 
Virus infectivity titer 
in supernatants 
(TCIDsojml±SEM)a 
104 •22 ±0.05 
104 .12 ± 0.06 
104 .12 ±0.06 
104 •32 ±0.03 
103 •87 ±0.26 b 
104.33 ± 0.10 b 
a Means of infectivity titer of four tubes, ± SEM, each titer is calculated from the 
results of 8 weHs per log 10 dilution. 
b Difference of VO between normal and immune adherent ceHs is significant (P< 0.01). 
Virus Specijicity oj Macrophage Dependent Injectivity Titre Reduction 
To test whether the activity of vaccinia immune macrophages was virus specific 
different groups of mice were injected intraperitoneally with 2 ml BCG suspension 
containing approximately 2.5 X 106 viable organisms (BCG, Behringwerke, Mar-
burg), 2 ml herpes simplex virus type I (106. 5 TCID50jml) or 2 ml vaccinia virus 
(105.5 TCID5o jml). PEC were collected six days later and tested for the capability 
to reduce vaccinia virus infectivity titre. Results are shown in Figure 3. 
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Fig. 3. Virus specificity of vaccinia virus clearance by PEO from mice immunized with 
different antigens 
SC and SEM of 4 titrations. Antigens were injected 6 days previously, 6 animals per group 
a) Normal PEO 
b) 2.5x 106 viable BOG organisms 
c) 1 ml 1 X 106 TOIDöo/ml herpes simplex virus type I 
d) 1 ml 1 X 106 TOIDso/ml vaccinia virus 
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PEC obtained from mice immunized with virus showed a higher percentage of 
virus clearance as compared to PEC from normal or BCG infected animals. While 
ceHs from vaccinia infected mice had the highest virus clearance the difference 
between herpes and vaccinia virus infected animals was not significant. The results 
with BCG did not significantly differ from normal. 
Virus Propagation in P EO 
We investigated whether the engulfed or adsorbed virus was propagated or 
inactivated in macrophages. Tubes containing PEC in 0.5 ml MEM from normal 
or immune mice were incubated with 0.5 ml virus suspension. After the incubation 
time of 4 hours the ceHs were spun down and virus titration was performed from 
the supernatants, the results showed the usual immune ceH specific virus clearance. 
The ceHs in the tubes were washed three times and resuspended in 1 ml medium 
consisting of MEM with 10 per cent calf serum, 1 per cent non-essential amino 
acids and 200 mM glutamine and incubated at 36° C in humidified 5 per cent CO 2 
atmosphere. On the second and fourth day the ceHs were fed with fresh medium. 
Tubes containing normal or immune PEC were washed and frozen at _20° C 
2 hours, 2, 3,4,5 and 6 days 1ater. At the end of the experiment all tubes were 
frozen and thawed three times to release intraceHular virus. Titrations were 
performed in Vero cells. The infectivity titre of the tubes containing ceHs from 
immunized animals remained constant over the whole period, whi1e infectivity 
titre in normal ceHs increased one log 10 step. These data show clearly a prolifera-
tion of vaccinia virus in normal PEC, while there was no propagation of virus in 
PEe from immunized animals (Fig. 4). 
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Fig. 4. Restricted propagation oi vaccinia virus in PEe from immunized mice 
.---li Infectivity titre in PEe from normal mice, • - -- - • Infectivity titre 
in PEe from immune mice 
Infectious Oentre Assay 
The release of engulfed or adsorbed infective virus partic1es was investigated 
with the infectious centre assay. Table 2 shows the results of a representative 
assay using FEC from immune mice infected 6 days previously. These ceHs had a 
higher virus clearance, and the data additionally show, that the cleared virus was 
released in smaller amounts from these cells than from PEC of normal animals. 
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This eapaeity to retain the infeetive virus was time dependent. In PEC examined 
1, 3, 5 and 7 days after immunization, reduction of infective centres compared 
to normal cells were seen first with cells harvested on the fifth day after infection. 
Plaques 
Per dish C 
Table 2. Release 0/ Virus by PEC tram Normal and Immune Mice a 
Normal PEC Immune PECb 
15± 1.95 4.7±2.33 d 
a Virus was adsorbed for 4 hours to PEC. After the washing proeedures eells were 
plated in a eoneentration of 100 eellsJml on Vero-eell monolayers. 
b Miee infeeted one week before harvesting of eeHs. 
e Plaques were eounted 72 hanrs after plating. 
d X and SEM from 6 dishes per group, differenees are significant (P<0.01). 
Action 0/ Antibodies on Macrophage Mediated Virus Clearance 
To investigate the possibility that macrophage media ted virus clearance is 
mediated entirely or in part by cytophilic antobodies, blocking experiments with 
anti-mouse IgG were performed in tubes containing 5 X 106 PEC (each assay 
was performed fourfold). PEC in 0.5 MEM from one time and three times injected 
mice, derived from 8 mice per group, were preincubated for 30 minutes at 37° C 
with 0.1 ml rabbit anti-mouse IgG (Microbiol. Ass. Bethesda, Maryland, Cat.No. 
52-122). Control tubes were run with normal rabbit serum. After this procedure the 
viability of the cell suspension was 95 per cent. To each tube 0.5 ml virus suspension 
containing 104. 5 TCID50/mi of vaccinia virus was added and after a further incuba-
tion period of 2 hours titrations of supernatants were performed. 
Comparison of the mean values in each group gave evidence that PEC from 
mice injected once with vaccinia virus and harvested after six days, react differ-
ently from PEC from three times injected mice, harvested two weeks after the 
first injection. After incubation with anti-mouse-IgG the ability of PEC from mice 
injected repeatedly with vaccinia to clear virus, was inhibited (Table 3). These 
results suggest that the VC in PEC from three times virus injected mice is media ted 
by cytophilic antibodies. Addition of complement to PEC incubated with anti-
mouse IgG gave essentially the S:1me results. Experiments performed in order to 
fix syngeneic strongly neutralizing anti-vaccinia antibodies to normal macro-
phages in order to activate the VC of normal cells. The fixation procedure was 
performed by incubating 1 X 106 PEC in 0.5 ml serum for 30 minutes at 4 ° 01' 35° C, 
followed by repeated washings of the cells. No activation of these cells could be 
observed. 
Anti vaccinia antibodies only partially neutralize vaccinia virus. We tested, 
whether the percentage oE VC by normal PEC was increased in presence of vaccinia 
antibodies. In this test activities of antibody alone and activation of PEC by 
antibodies had to be differentiated. Therefore the value of the infectivity titer 
in the controls containing only antibody and vaccinia virus suspension was taken 
as 100 per cent. The further reduction of infectivity titer after addition of PEC 
was attributed to these cells. Normal PEC usually clear about 25 per cent of a 
given vaccinia virus suspension. If they were incubated with an antigen-antibody 
suspension 85 per cent of unneutralized virus was taken up. 
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The antiserum was fractionated by gel chromatography to examine whether 
this activation was caused by IgM or IgG antibodies. The IgM and the IgG peaks 
were found in fraction number 18 and 26, tested by photometrie and electro-
phoretic means. These fractions were tested for neutralizing and macrophage 
mediated VC augmenting activity. The fractions of 1.5 ml were diluted 1:4 in MEM 
andto 0.5 ml sampies 0.5 ml virus suspension (104.5 TCID5o/ml) and 5 X 106 PEC 
in 0.5 ml medium were added. To test unspecific activities of the serum, fraction 22 
was tested as control. The results in Figure 5 show the representative results of 
one of the repeated performed experiments. Cell activation was seen in the IgG 
fraction. The IgM fraction and the control fraction had on1y slight neutralizing 
activities but did not activate normal PEC to increased virus c1earance. 
Table 3. Action 0/ Anti-~'I1ou8e-Ig on the VC 01 Vaccinia by PEC 
Pretreatment of cells 
Anti-mouse Igc 
a Harvested at day 6. 
b Harvested at day 14 
Percent VC 
PEC from mice injected with vaccinia 
1 timea 3 timesb 
56±3.67 
59±9.00 
6S±S.OS 
3± 10.39d 
c 5 X 106 PEC in 0.5 ml were preincubated with 0.1 ml anti-mouse-Ig for 2 hours. 
d X and SEM of four tubes per group. Significant reduction of VC (P<O.Ol). 
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Fig. 5. The effect of IgM and IgG fractions on the vaccinia antibody induced VC of 
PEC from normal mice 
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Discussion 
Problems may arise in interpreting the results of in vitra activities of macro-
phages due to differences in culture conditions. Prolonged in vitra cultures may 
unspecifically enhance activities as we could see in our tests or cause losses of 
the immune state (22). Serum may activate macrophages by opsonization of 
antigens (16). Ingestion of particles is possible without serum in the culture but 
attachment and uptake of particles may be differently dependent on the presence 
of serum (17, 18). 
Peritoneal exudate cells (PEC) from vaccinia immune mice have a significant 
higher virus clearance capacity than normal PEC. In other systems increased 
virus clearance (VC) activities of immune macrophages on influenza virus (4) 
fibroma virus (9) and ectromelia virus (21) have been described. One has to 
consider that all the cells we tested were obtained from mice after stimulation with 
thioglycolate, the unspecific activity of "normal" cells may be attributed to 
this stimulation. The nonadherent cell fraction of PEC had no virus clearing 
activity. Purified macrophage monolayers had the highest activity. An activation 
by B- or T-ceHs with specific "arming" (7) in vitra can be ruled out. The higher VC 
of immune macrophages can be based on active phagocytosis, cytophilic anti-
bodies (CA) or on adsorption to receptors for viruses on the surface membranes 
of macrophages (26). 
The further interactions between virus and macrophages were investigated 
by the growth curve studies. The infectivity titre of engulfed virus in PEC from 
immune mice remained constant during cultivation for six days while an intra-
cellular propagation was seen in normal PEC. Therefore immune PEC show not 
only different action on the virus but also modified resistance to infection. The 
resistance of macrophages is independent of the presence of other lymphoid cells 
(22), virus specificity is shown since macrophages are only resistant to the virus 
to which the animals have been immunized (1). In similar experiments using 
vaccinia virus with rabbits (22, 24) and mice (25) differences between normal and 
immune ceHs can be demonstrated, while in experiments with alveolar macro-
phages of rabbits no differences are seen (3) and normal macrophages of rats (6) 
and mice (15) lead to a reduction of viral infectivity titer. Also unspecific stimulat-
ed macrophages cause a titre reduction in other virus infections (23,26). Therefore 
results concerning antiviral activities of macrophages obtained from experiments 
with a given virus can, if at all , only be partially compared with results found by 
investigating other viruses. 
The findings of the infectious centre assay support the postulation that immune 
PEC show a different response to vaccinia infection. Significantly smaHer amounts 
of infectious virus particles are re]eased as compared to normal cells, which could 
have positive effects if this would occur in viva. This effect cannot be attributed 
to virus inactivation as it may be in other virus infections (10, 19) since the growth 
studies demonstrate that the vaccinia virus is not inactivated during the period 
tested. 
VC of vaccinia virus by normal macrophages is enhanced after addition of 
IgG anti vaccinia antibodies. Similar effects have been obtained by blood 
clearance assays after injections of vesicular stomatitis virus and newcastle 
Arch. Virol. 48/4 24 
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disease virus together with specific antibodies (5). Whether this effect can be 
contributed to the formation of infective antigen antibody complexes, to opsoniza-
tion or to cytophilic antibodies remains to be defined. Efforts we made to adsorb 
antibodies passively to macrophages were unsuccessful. 
The immune activity of macrophages is at least partially caused by cybophilic 
antibodies (25). They can be raised by immunization with vaccinia emulsified in 
complete Freund's adjuvant and belong to the IgG immunoglobulins (22). In our 
experiments we could indirectly demonstrate the action of cybophilic antibody 
by blocking experiments. VC activity of PEC from repeatedly injected mice can 
be entirely blocked by anti-mouse-IgG. This was not the case when using PEC 
from mice six days after a single injection of virus. 
One can conclude that macrophages dcvelop specific and unspecific immune 
activities in vitra to viral particles independent of the presence of other lymphoid 
cells. The va of macrophages seems to be at least partially unspecific, but the 
restriction of virus propagation has proved to be virus specific (1). Additionally 
the cleared virus is released only in small amounts. Cytophilic antibodies can 
mediate macrophage activities in later stages of infection. In early stages of 
infection the macrophage activity seems to be media ted by other mechanisms 
since the blocking of cytophilic antibody by anti-IgG antibodies is ineffective. 
It is likely that the restriction of virus propagation in vaccinia virus sensitized 
PEC harvested one week after injection is also independent of cybophilic antibody. 
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